NCT07189702Not yet recruiting
Plant-Based Nutrition for Breast or Endometrial Cancer
A Randomized Controlled Trial of Behavioral Education and Nutrition Delivery in Women With Metastatic Breast and Endometrial Cancer. (The BEND-MBEC Study)
Source: ClinicalTrials.gov · Last updated 8 Apr 2026
Brief summary (registry, in English)
This is a randomized controlled trial of a whole food, plant-based (WFPB) dietary intervention among women with metastatic breast or endometrial cancer.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 12 Sept 2025
- Start date
- 1 Dec 2026
- Primary completion date
- 31 Dec 2029
- Lead sponsor
- University of Rochester
- NCT number
- NCT07189702
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 1 Dec 2026 to the primary completion date, 31 Dec 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Active malabsorption syndrome at time of consent, as determined by study physicians (i.e. Crohn's disease, bowel surgery)
- Any food allergies or intolerances that would interfere with study compliance
- Cognitive impairment or psychiatric disorder impairing ability to give consent.
Lab values
- eGFR \< 30 on ≥ two lab tests in the past six months
- Serum potassium \> 5.4 in the past six months
Other
- Inability to tolerate a normal diet
- Recent consumption (in the past six months) of a vegan diet
- Current insulin or sulfonylurea use
- Current warfarin use (non-vitamin K antagonist allowed)
- High-risk alcohol use (\>7 drinks/wk)
- Illicit substance use (not including marijuana)
Who the study is looking for
- A confirmed diagnosis of endometrial or metastatic breast cancer. All subtypes are eligible
- Treating oncologist approval and expected survival of at least six months
- Undergoing any systemic treatment including hormonal, cytotoxic, targeted monoclonal antibody or small molecule kinase inhibitors or any combination of the above. Women who have active cancer and have been recommended but declined systemic treatment are also eligible.
- Willing to adopt a strict, whole-foods, plant-based diet
- Willing and able to comply with the WFPB protocol for the duration of the study including scheduled testing, Zoom meetings, and office visits
- Able to speak and read English fluently.
- Women with plans for radiation therapy or surgery are also eligible provided that they meet all other eligibility criteria.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.